Unique metabolism of a novel antiviral L-nucleoside analog, 2'-fluoro- 5-methyl-β-L-arabinofuranosyluracil: A substrate for both thymidine kinase and deoxycytidine kinase

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 833-839

  Liu, Shwu Huey ^a   Grove, Kristie L ^a   Cheng, Yung Chi ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CLEVUDINE; DEOXYCYTIDINE KINASE; NUCLEOSIDE ANALOG; THYMIDINE KINASE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSPORT; ENZYME SUBSTRATE; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 0031979178     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.833     Document Type: Article

References (30)

1. Ayoola, E. A., M. S. Balayan, F. Deinhardt, I. Gust, A. W. Kureshi, J. E. Maynaed, N. C. Nayak, D. W. Brodley, M. Ferguson, J. Melnick, R. H. Purcell, and A. J. Zuckerman. 1988. Progress in the control of viral hepatitis: memorandum from a WHO meeting. Bull. W. H. O. 66:443-455.
2. Bridges, E. G., and Y.-C. Cheng. 1996. Use of novel β-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma. Prog. Liver Dis. 13:231-245.
3. Chang, C.-N., S.-L. Doong, J. H. Zhou, J. W. Beach, L. S. Jeong, C. K. Chu, C.-H. Tsai, and Y.-C. Cheng. 1992. Deoxycytidine deaminase-resistant stereoisomer is the active form of (±)-2′-3′-dideoxy-3′-thiacytidine in the inhibition of hepatitis B virus replication. J. Biol. Chem. 267:13938-13942.
4. Cheng, Y. C., B. Domin, and L.-S. Lee. 1977. Human deoxycytidine kinase. Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients. Biochim. Biophys. Acta 481:481-492.
5. Cheng, Y.-C., G. Dutschman, J. J. Fox, K. A. Watanabe, and H. Machida. 1981. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother. 20:420-423.
6. Chou, T.-C., J. H. Burchenal, F. A. Schmid, T. J. Braun, T.-L. Su, K. A. Watanale, J. J. Fox, and F. S. Philips. 1982. Biochemical effects of 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil and 2′-fluoro-5-iodo-1-β-D-arabinofuranosylcytidine in mouse leukemic cells sensitive and resistant to 1-β-D-arabinofuranosylcytosine. Cancer Res. 42:3957-3963.
7. Chu, C. K., T. Ma, K. Shammuganathan, C. Wang, Y. Xiang, S. B. Pai, G. Q. Yao, J. P. Sommadossi, and Y. C. Cheng. 1995. Use of 2′-fluoro-5-β-L-arabinofuranosyl uracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob. Agents Chemother. 39:979-981.
8. Dahlig-Harley, E., Y. Eilam, A. R. Paterson, and C. E. Cass. 1981. Binding of nitrobenzylthioinosine to high-affinity sites on the nucleoside-transport mechanism of HeLa cells. Biochem. J. 200:295-305.
9. Doong, S.-L., C.-H. Tsai, R. F. Schinazi, D. C. Liotta, and Y.-C. Cheng. 1991. Inhibition of the replication of hepatitis B virus in vitro by 2′-3′-dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA 88:8495-8499.
10. Furman, P. A., M. Davis, D. C. Liotta, M. Paff, L. W. Frick, D. J. Nelson, R. E. Dornsife, J. A. Wurster, L. J. Wilson, and J. A. Fyfe. 1992. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2686-2692.
11. Gosselin, G., R. F. Schinazi, J. P. Sommadossi, C. Mathe, M. C. Bergogne, A. M. Aubertin, A. Kirn, and J. L. Imbach. 1994. Anti-human immunodeficiency virus activities of the β-L-enantiomer of 2′-3′-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrob. Agents Chemother. 38:1292-1297.
12. Johnson, M. A., and A. Fridland. 1989. Phosphorylatron of 2′-3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol. Pharmacol. 36:291-295.
13. Kowal, E. P., and G. Markus. 1976. Affinity chromatography of thymidine kinase from a rat colon adenocarcinoma. Prep. Biochem. 6:369-385.
14. Lauzon, G. J., and A. R. P. Paterson. 1977. Binding of the nucleoside transport inhibitor nitrobenzylthioinosine to HeLa cells. Mol. Pharmacol. 13: 883-891.
15. Lee, L. S., and Y. C. Cheng. 1976. Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia. J. Biol. Chem. 251: 2600-2604.
16. Lee, M., C. K. Chu, S. B. Pai, Y.-L. Zbu, Y.-C. Cheng, M. W. Chun, and W. K. Chung. 1995. Dioxolane cytosine nucleosides as anti-hepatitis B agents. Bioorg. Med. Chem. Lett. 17:2011-2014.
17. Lin, T.-S., M.-Z. Luo, M.-C. Liu, Y.-L. Zhu, E. Gullen, G. E. Dutschman, and Y.-C. Cheng. 1996. Design and synthesis of 2′,3′-dideoxy-2′,3′-didehydro-β-L-cytidine (β-L-d4C) and 2′,3′-dideoxy-2′,3′-didehydro-β-L-5-fluorocytidine (β-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro. J. Med. Chem. 39:1757-1759.
18. Ling, R., D. Mutimer, M. Ahmed, E. H. Boxall, E. Elias, G. M. Dusheiko, and T. J. Harrison. 1996. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology. 24:711-713.
19. Muller, R., R. Baumgarten, R. Markus, M. Schults, H. Wittenburger, B. Hintsche-Kilger, J. D. Fengler, P. Von Wussow, H. Meisel, H. Klein, K. Malmus, and F. W. Schmidt. 1990. Treatment of chronic hepatitis B with Interferon alfa-2b. J. Hepatol. 11:s137-s140.
20. Munch-Petersen, B., L. Cloos, G. Tyrsted, and S. Eriksson. 1991. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 266:9032-9038.
21. Pai, S. B., S. H. Liu, Y. L. Zhu, C. K. Chu, and Y. C. Cheng. 1996. Inhibition of hepatitis B virus by a novel L-nucleoside, 2′-fluoro-5-β-L-arabinofuranosyl uracil. Antimicrob. Agents Chemother. 40:380-386.
22. Parker, W. B., and Y. C. Cheng. 1994. Mitochondrial toxicity of antiviral nucleoside analogs. J. NIH Res. 6:57-61.
23. Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415.
24. Szmuness, W. 1978. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog. Med. Virol. 24:40-69.
25. Tipples, G. A., M. M. Ma, K. P. Fischer, V. G. Bain, N. M. Kneteman, and D. L. J. Tyrrell. 1996. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.
26. Voytek, P., P. K. Chang, and W. H. Prusoff. 1971. Purification of deoxythymidine kinase by preparative disc gel electrophoresis and the effects of various halogenated nucleoside triphosphate on its enzymatic activity. J. Biol. Chem. 246:1432-1438.
27. Yao, G. Q., S. H. Liu, E. Chou, M. Kukhanova, C. K. Chu, and Y. C. Cheng. 1996. Inhibition of Epstein-Barr virus replication by a novel-L-nucleoside, 2′-fluoro-5-β-L-arabinofuranosyluracil. Biochem. Pharmacol. 51:941-947.
28. Yao, G. C., C. H. Tsai, and Y. C. Cheng. 1995. Characterization of sublines of Epstein-Barr virus producing HR-1 cells and its implication in virus propagation in culture. Virus Genes 9:247-255.
29. Zoulim, F., E. Dannaoui, C. Borel, O. Hantz, T.-S. Lin, S.-H. Liu, C. Trepo, and Y.-C. Cheng. 1996. 2′,3′-Dideoxy-β-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo. Antimicrob. Agents Chemother. 40: 448-453.
30. Zoulim, F., S. Aguesse, C. Trepo, M. Chevalier, and Y. C. Cheng. Personal communication.